Logo image of XBC.CA

Xebec Adsorption Inc (XBC.CA) Stock Fundamental Analysis

TSX:XBC - Toronto Stock Exchange - CA9838911027 - Common Stock - Currency: CAD

0.51  +0.01 (+2%)

Fundamental Rating

2

XBC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Machinery industry. Both the profitability and financial health of XBC have multiple concerns. XBC shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XBC had negative earnings in the past year.
XBC.CA Yearly Net Income VS EBIT VS OCF VS FCFXBC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -9.68%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XBC.CA Yearly ROA, ROE, ROICXBC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -500 -1K -1.5K

1.3 Margins

Industry RankSector Rank
OM -27.63%
PM (TTM) -30.79%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XBC.CA Yearly Profit, Operating, Gross MarginsXBC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

XBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XBC has more shares outstanding
XBC has a worse debt/assets ratio than last year.
XBC.CA Yearly Shares OutstandingXBC.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M
XBC.CA Yearly Total Debt VS Total AssetsXBC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -0.15, we must say that XBC is in the distress zone and has some risk of bankruptcy.
XBC has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACCN/A
WACC11.12%
XBC.CA Yearly LT Debt VS Equity VS FCFXBC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

XBC has a Current Ratio of 1.23. This is a normal value and indicates that XBC is financially healthy and should not expect problems in meeting its short term obligations.
XBC has a Quick Ratio of 1.23. This is a bad value and indicates that XBC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.81
XBC.CA Yearly Current Assets VS Current LiabilitesXBC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

7

3. Growth

3.1 Past

XBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.50%, which is quite impressive.
The Revenue has grown by 102.90% in the past year. This is a very strong growth!
XBC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.36% yearly.
EPS 1Y (TTM)22.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150%
Revenue 1Y (TTM)102.9%
Revenue growth 3Y84%
Revenue growth 5Y67.36%
Sales Q2Q%36.24%

3.2 Future

The Earnings Per Share is expected to grow by 14.02% on average over the next years. This is quite good.
XBC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.57% yearly.
EPS Next Y-111.99%
EPS Next 2Y23.77%
EPS Next 3Y25.55%
EPS Next 5Y14.02%
Revenue Next Year57.84%
Revenue Next 2Y48.43%
Revenue Next 3Y35.6%
Revenue Next 5Y31.57%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XBC.CA Yearly Revenue VS EstimatesXBC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
XBC.CA Yearly EPS VS EstimatesXBC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XBC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XBC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XBC.CA Price Earnings VS Forward Price EarningsXBC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -4.02
XBC.CA Per share dataXBC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

XBC's earnings are expected to grow with 25.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.77%
EPS Next 3Y25.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Xebec Adsorption Inc

TSX:XBC (9/28/2022, 7:00:00 PM)

0.51

+0.01 (+2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.49%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.91M
Analysts51.67
Price Target1.4 (174.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.5
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB N/A
EV/EBITDA -4.02
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.02
BVpS1.68
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.68%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -27.63%
PM (TTM) -30.79%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.81
Altman-Z -0.15
F-Score3
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150%
EPS Next Y-111.99%
EPS Next 2Y23.77%
EPS Next 3Y25.55%
EPS Next 5Y14.02%
Revenue 1Y (TTM)102.9%
Revenue growth 3Y84%
Revenue growth 5Y67.36%
Sales Q2Q%36.24%
Revenue Next Year57.84%
Revenue Next 2Y48.43%
Revenue Next 3Y35.6%
Revenue Next 5Y31.57%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A